| MeSH term | MeSH ID | Detail |
|---|---|---|
| Weight Gain | D015430 | 101 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Total
3
all-trans-retinyl Palmitate
All-trans-retinyl palmitate is a lipid of Prenol Lipids (PR) class. All-trans-retinyl palmitate is associated with abnormalities such as Wiskott-Aldrich Syndrome.
Cross Reference
Introduction
To understand associated biological information of all-trans-retinyl Palmitate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with all-trans-retinyl Palmitate?
all-trans-retinyl Palmitate is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with all-trans-retinyl Palmitate
PubChem Associated disorders and diseases
What pathways are associated with all-trans-retinyl Palmitate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with all-trans-retinyl Palmitate?
There are no associated biomedical information in the current reference collection.
What functions are associated with all-trans-retinyl Palmitate?
There are no associated biomedical information in the current reference collection.
What lipids are associated with all-trans-retinyl Palmitate?
There are no associated biomedical information in the current reference collection.
What genes are associated with all-trans-retinyl Palmitate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with all-trans-retinyl Palmitate?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with all-trans-retinyl Palmitate
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Babamiri K and Nassab R | Cosmeceuticals: the evidence behind the retinoids. | 2010 | Aesthet Surg J | pmid:20442078 |
| Wang SQ et al. | Safety of retinyl palmitate in sunscreens: a critical analysis. | 2010 | J. Am. Acad. Dermatol. | pmid:20692724 |
| Gronowska-Senger A et al. | [Retinyl palmitate and oxidative stress reduction in rats]. | 2010 | Rocz Panstw Zakl Hig | pmid:20803896 |
| Chen S et al. | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 2010 | Biochem. Pharmacol. | pmid:19686701 |
| Brader L et al. | Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects. | 2010 | Nutr Metab Cardiovasc Dis | pmid:19473824 |
| Albertini B et al. | Encapsulation of Vitamin A palmitate for animal supplementation: Formulation, manufacturing and stability implications. | 2010 | J Microencapsul | pmid:19538031 |
| Dvorák J et al. | Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation. | 2010 | Med. Oncol. | pmid:19629763 |
| de Oliveira MR et al. | Pharmacological doses of vitamin A increase caspase-3 activity selectively in cerebral cortex. | 2010 | Fundam Clin Pharmacol | pmid:19889026 |
| Davydova N et al. | Development and validation of a dissolution test method for vitamin A in dietary supplement tablets. | 2010 | J Pharm Biomed Anal | pmid:20427140 |
| Hubinger JC | Determination of retinol, retinyl palmitate, and retinoic acid in consumer cosmetic products. | 2009 Sep-Oct | J Cosmet Sci | pmid:19822106 |
| Mei N et al. | UVA-induced photomutagenicity of retinyl palmitate. | 2009 Jun-Jul | Mutat. Res. | pmid:19477293 |
| Marisiddaiah R and Baskaran V | Bioefficacy of beta-carotene is improved in rats after solubilized as equimolar dose of beta-carotene and lutein in phospholipid-mixed micelles. | 2009 | Nutr Res | pmid:19761893 |
| Dufour EK et al. | Retinyl palmitate is non-genotoxic in Chinese hamster ovary cells in the dark or after pre-irradiation or simultaneous irradiation with UV light. | 2009 | Mutat. Res. | pmid:18977457 |
| Qiao YL et al. | Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. | 2009 | J. Natl. Cancer Inst. | pmid:19318634 |
| Noto D et al. | Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. | 2009 | Atherosclerosis | pmid:19344897 |
| Saintigny P et al. | DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. | 2009 | Clin. Cancer Res. | pmid:19773378 |
| Kim EC et al. | A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. | 2009 | Am. J. Ophthalmol. | pmid:18848318 |
| Reboul E et al. | ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha- and gamma-tocopherol but not in that of retinyl palmitate in mice. | 2009 | Am. J. Clin. Nutr. | pmid:19056557 |
| Papadimitrakopoulou VA et al. | Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. | 2009 | J. Clin. Oncol. | pmid:19075276 |
| Nikolaeva O et al. | Purified RPE65 shows isomerohydrolase activity after reassociation with a phospholipid membrane. | 2009 | FEBS J. | pmid:19490105 |